Transforming
Glioblastoma
Therapy
About
Overview
Advisory Board
A Message from the CEO
Contact Us
Research
Preclinical Models
Repurposing Existing Therapies
Ultrasound Therapy
Early Detection
Get Involved
Donate Now
Volunteer
Become a Supporter
Corporate Supporters
2112 Tribute
Meet Morgan Myles
Patients
Information about Glioblastoma
Tell Us Your Story
Glioblastoma Patient and Caregiver Support Groups
Patient Stories
Voices of Glioblastoma
News
2023 Los Angeles Marathon
Glioblastoma in the Media
Blog
Donate
Fundraise
About
Overview
Advisory Board
A Message from the CEO
Contact Us
Research
Preclinical Models
Repurposing Existing Therapies
Ultrasound Therapy
Early Detection
Get Involved
Donate Now
Volunteer
Become a Supporter
Corporate Supporters
2112 Tribute
Meet Morgan Myles
Patients
Information about Glioblastoma
Tell Us Your Story
Glioblastoma Patient and Caregiver Support Groups
Patient Stories
Voices of Glioblastoma
News
2023 Los Angeles Marathon
Glioblastoma in the Media
Blog
Donate
Fundraise
Home
>
Glioblastoma Foundation Expands Trial to Study Osimertinib
>
Pills_Pink_Download
Pills_Pink_Download
The current standard of care for glioblastoma consisting of radiation and chemotherapy is ineffective.
Help Us Transform Glioblastoma Therapy
Donate
